HMOX2 and Hyperglycemia: The acute hyperglycaemia did influence neither the HO1 nor the HO2 expression 3, 5, or 10 days after the STZ treatment as compared to controls (19.35 ± 0.98 versus 18.09 ± 0.77 versus 18.76 ± 1.23 ng/mg protein in the case of HO1 and 27.76 ± 0.92 versus 28.66 ± 1.02 versus 27.72 ± 1.31 ng/mg protein in the case of HO2, resp).